Observational studyThe journal of prevention of Alzheimer's disease2026

Interim analysis of all-case post-marketing surveillance study in Japan: lecanemab in patients with early Alzheimer's disease.

Atsushi Iwata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.